<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04709809</url>
  </required_header>
  <id_info>
    <org_study_id>2017-01036</org_study_id>
    <nct_id>NCT04709809</nct_id>
  </id_info>
  <brief_title>Analysis of Retinal Vessel Pulsations With Electrocardiographic Gating</brief_title>
  <official_title>Analysis of Retinal Vessel Pulsations With Electrocardiographic Gating</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analysis of Retinal Vessel Analyzer (RVA) recordings of retinal vessel pulsations, and&#xD;
      putting them in context of intraocular pressure (IOP) pulsations by means of&#xD;
      electrocardiographic (ECG) gating, in order to determine the lead source for pulsations of&#xD;
      retinal veins.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale / Objective is to construct the retinal vessels wall pulsation cycle using an&#xD;
      electrocardiographic gating, and to analyse it in comparison with an analogue intraocular&#xD;
      pressure (IOP) cycle.&#xD;
&#xD;
      Based on the amplitude and on the phase shift of pulsations of retinal vessel wall, the goal&#xD;
      is to identify a lead source of the retinal venous pulsations (IOP pulsations, or alternative&#xD;
      sources, e.g. cerebrospinal fluid pulsations).&#xD;
&#xD;
      Subjects will be recruited from the environment of the master thesis medical students,&#xD;
      colleagues and friends and the informed consent will be handed to them personally. Exclusion&#xD;
      criteria will be addressed. One random eye per subject will be selected. On the study day,&#xD;
      first the mydriasis drops - phenylephrine + tropicamide - will be applied, then ECG&#xD;
      electrodes attached; 20 minutes after the mydriasis drops, the first set of measurements will&#xD;
      be performed: RVA recording with ECG gating, and Pascal Dynamic Contour Tonometry (DCT)&#xD;
      recording with ECG gating. Ten minutes after this measurements, 100% oxygen 5 liters/min&#xD;
      through nasal cannula will be applied for 2 minutes and then the same measurements repeated.&#xD;
      Approximate time needed for the whole run - around 60 minutes per subject, including&#xD;
      (dis)mounting the ECG electrodes and the mydriasis time.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Data driven analysis</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Phase shift between pulsations</measure>
    <time_frame>day 1</time_frame>
    <description>No phase shift versus phase shift between the venous amplitude maximum and the IOP pulsation maximum.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Vessels; Anomaly</condition>
  <arm_group>
    <arm_group_label>Experimental arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measurement RVA / IOP / with ECG gating</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Retinal Vessel Analyzer recordings with electrocardiographic (ECG) gating</intervention_name>
    <description>Video recordings of ocular fundus, an analysis of dynamic vessel diameters and putting them in ECG context.</description>
    <arm_group_label>Experimental arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Known ophthalmological disease, in particular vascular disease.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Basel</city>
        <state>Base√∂</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 11, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2021</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

